Latest Breaking News On - Panbela therapeutics daily - Page 1 : comparemela.com

Panbela Therapeutics (PBLA) Neutral Rating Reaffirmed at HC Wainwright

Panbela Therapeutics (NASDAQ:PBLA – Get Free Report)‘s stock had its “neutral” rating restated by investment analysts at HC Wainwright in a research report issued to clients and investors on Thursday, Benzinga reports. Separately, Roth Mkm reiterated a “buy” rating on shares of Panbela Therapeutics in a research note on Wednesday, March 27th. Get Our Latest […]

Roth mkmPanbela therapeutics incPanbela therapeuticsGet free reportPanbela therapeutics daily

Short Interest in Panbela Therapeutics, Inc (NASDAQ:PBLA) Drops By 22 2%

Panbela Therapeutics, Inc. (NASDAQ:PBLA – Get Free Report) was the target of a large decline in short interest in the month of November. As of November 15th, there was short interest totalling 64,900 shares, a decline of 22.2% from the October 31st total of 83,400 shares. Currently, 1.3% of the company’s shares are short sold. […]

Vanguard group incPanbela therapeutics company profileSecurities exchange commissionPanbela therapeutics incWalleye capitalGoldman sachs group incPanbela therapeuticsGet free reportExchange commissionFunds managementVanguard groupPanbela therapeutics dailyNasdaq pbla

Panbela Therapeutics, Inc (NASDAQ:PBLA) Sees Significant Drop in Short Interest

Panbela Therapeutics, Inc (NASDAQ:PBLA) Sees Significant Drop in Short Interest
kopsource.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from kopsource.com Daily Mail and Mail on Sunday newspapers.

Walleye capitalGoldman sachs group incPanbela therapeutics incVanguard group incPanbela therapeutics company profilePanbela therapeuticsGet free reportFunds managementVanguard groupPanbela therapeutics daily

Panbela Therapeutics, Inc (NASDAQ:PBLA) Sees Large Decrease in Short Interest

Panbela Therapeutics, Inc. (NASDAQ:PBLA – Get Free Report) saw a significant drop in short interest during the month of November. As of November 15th, there was short interest totalling 64,900 shares, a drop of 22.2% from the October 31st total of 83,400 shares. Currently, 1.3% of the company’s shares are short sold. Based on an […]

Goldman sachs group incVanguard group incPanbela therapeutics incPanbela therapeutics company profilePanbela therapeuticsGet free reportFunds managementAltium capital managementPanbela therapeutics dailyNasdaq pbla

Goldman Sachs Group Inc Sells 72,874 Shares of Panbela Therapeutics, Inc (NASDAQ:PBLA) Stock

Panbela Therapeutics, Inc. (NASDAQ:PBLA – Get Free Report) major shareholder Goldman Sachs Group Inc sold 72,874 shares of the firm’s stock in a transaction dated Wednesday, November 8th. The stock was sold at an average price of $0.71, for a total value of $51,740.54. Following the completion of the transaction, the insider now owns 397,954 […]

Panbela therapeutics incGoldman sachs group incVanguard group incPanbela therapeutics company profileWalleye capitalPanbela therapeuticsGet free reportFunds managementVanguard groupPanbela therapeutics dailyNasdaq pblaInsider tradingNsider trades